Clinical Trials Directory

Trials / Completed

CompletedNCT03554629

A Comparison of Capnography Sampling Lines

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Medtronic - MITG · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study evaluates the performance of eight (8) cleared capnography carbon dioxide (CO2) sampling filterlines during patient simulated scripted activities when connected to a Medtronic (MDT) dual parameter monitor.

Detailed description

The eight (8) Capnography CO2 Sampling Filterlines (CCSF) have different designs for obtaining a gas sample for CO2 measurement and also for delivering supplemental oxygen (O2). In this study awake, healthy volunteers will evaluate the 8 CCSF (Capnography CO2 Sampling Filterline) to determine their performance variability in providing a representative exhaled CO2 sample for measurement on the Capnostream 35 dual parameter monitor during scripted activities of closed mouth/open mouth breathing during both high and low respiration rate with supplemental oxygen delivery at 5lpm.

Conditions

Interventions

TypeNameDescription
DEVICECapnography CO2 cannula sampling Flexiterline (CCSF) designs with supplemental O2Use of 8 post-market nasal CO2 cannula sampling filterlines; 4 nasal only sampling ports manufactured by Medtronic, Salter, Hudson/Teleflex and FlexiCare) and 4 post-market oral/nasal sampling ports manufactured by Medtronic, Salter, Dispo-Med and Westmed during scripted activity with supplemental O2.

Timeline

Start date
2018-05-01
Primary completion
2019-08-31
Completion
2020-09-15
First posted
2018-06-13
Last updated
2021-01-06
Results posted
2020-12-16

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03554629. Inclusion in this directory is not an endorsement.